HIGH SUSANNA GATTI
SEC CIK 1691005 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | COO | 131.6K | — | $8.47M | 29 | 2021-09-23 | 2024-09-18 |
Most active insiders at DYN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rhodes Jason P | Dir | — | $129.10M |
| 2 | Kersten Dirk | Dir | — | $38.57M |
| 3 | Cox John | CEO, Pres, Dir | — | $443.7K |
| 4 | Posner Brian S | Dir | $274.8K | — |
| 5 | Kerr Douglas | Chief Medical Off | — | $233.1K |
| 6 | Lucera Erick | CFO | — | $228.7K |
| 7 | Friedl-Naderer Johanna | Chief Commercial Off | — | $43.4K |
| 8 | Lubner David Charles | Dir | — | — |
HIGH SUSANNA GATTI made no open-market trades at DYN in the last 12 months.
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-09-19 | 2024-09-18 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $34.41 | -8,976 | 131.6K | -6% | -$308.9K |
| MT | 2024-09-11 | 2024-09-11 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $31.89 | -5,270 | 140.6K | -4% | -$168.1K |
| MT | 2024-08-20 | 2024-08-19 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $45.12 | -2,910 | 145.9K | -2% | -$131.3K |
| DMAT | 2024-07-03 | 2024-06-21+ | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | M - OptEx | $5.54 | +40.0K | 178.6K | +29% | +$221.6K |
| DMAT | 2024-07-03 | 2024-06-21+ | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale+OE | $35.09 | -40.0K | 148.8K | -21% | -$1.40M |
| DMT | 2024-06-24 | 2024-06-21+ | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | M - OptEx | $5.54 | +40.0K | 159.0K | +34% | +$221.3K |
| DMT | 2024-06-24 | 2024-06-21+ | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale+OE | $35.09 | -40.0K | 148.8K | -21% | -$1.40M |
| DT | 2024-06-13 | 2024-06-12 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | M - OptEx | $5.54 | +40.0K | 188.8K | +27% | +$221.6K |
| DMT | 2024-06-13 | 2024-06-12 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale+OE | $33.36 | -40.0K | 148.8K | -21% | -$1.33M |
| DMT | 2024-06-11 | 2024-06-10+ | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale+OE | $30.30 | -85.3K | 154.1K | -36% | -$2.58M |
| DT | 2024-06-11 | 2024-06-10 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | M - OptEx | $5.54 | +80.0K | 234.1K | +52% | +$443.2K |
| MT | 2024-05-17 | 2024-05-16 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $28.27 | -2,738 | 154.6K | -2% | -$77.4K |
| MT | 2024-03-13 | 2024-03-08+ | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $26.59 | -29.5K | 159.1K | -16% | -$784.2K |
| T | 2024-03-11 | 2024-03-07 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $25.85 | -1,591 | 186.3K | -0.8% | -$41.1K |
| 2023-12-12 | 2023-12-11 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $10.72 | -1,616 | 187.9K | -0.9% | -$17.3K | |
| D | 2023-11-16 | 2023-11-15 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | A - Grant | $0.00 | +94.9K | 189.5K | +100% | $0 |
| 2023-11-02 | 2023-11-02 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $7.40 | -9,939 | 94.6K | -10% | -$73.5K | |
| 2023-09-20 | 2023-09-18 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $9.41 | -2,672 | 104.5K | -2% | -$25.1K | |
| 2023-09-13 | 2023-09-12 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $10.41 | -1,635 | 107.2K | -2% | -$17.0K | |
| 2023-06-14 | 2023-06-13 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $12.43 | -1,625 | 108.9K | -1% | -$20.2K | |
| 2023-03-15 | 2023-03-14 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $13.33 | -1,559 | 110.5K | -1% | -$20.8K | |
| D | 2022-12-13 | 2022-12-09 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | A - Grant | $0.00 | +44.0K | 112.8K | +64% | $0 |
| D | 2022-12-13 | 2022-12-12 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $10.87 | -751 | 112.0K | -0.7% | -$8,163 |
| 2022-09-21 | 2022-09-20 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | D - Sale to Iss | $13.70 | -2,629 | 68.8K | -4% | -$36.0K | |
| 2022-09-15 | 2022-09-15 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | D - Sale to Iss | $14.05 | -786 | 71.4K | -1% | -$11.0K | |
| 2022-06-15 | 2022-06-14 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | D - Sale to Iss | $4.95 | -802 | 72.2K | -1% | -$3,970 | |
| 2022-03-14 | 2022-03-11 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $8.73 | -765 | 73.0K | -1% | -$6,678 | |
| D | 2021-12-14 | 2021-12-10 | DYN | Dyne Therapeutics, Inc. | COO | A - Grant | $0.00 | +40.3K | 73.8K | +121% | $0 | |
| 2021-09-24 | 2021-09-23 | DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | COO | S - Sale | $17.22 | -2,451 | 33.5K | -7% | -$42.2K |
Purchase Sale Sale after option exercise All abbreviations